Cargando…
Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products
New technologies and our ever-increasing knowledge provide an exciting potential to develop innovative health products that can address challenges such as chronic diseases and ultimately improve outcomes for patients. Ireland has a strategic focus on supporting innovation and offers an ideal environ...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945904/ https://www.ncbi.nlm.nih.gov/pubmed/31988952 http://dx.doi.org/10.1159/000481427 |
_version_ | 1783485256856240128 |
---|---|
author | O'Dwyer, Laurence Nolan, Lorraine Fisher, Caitriona |
author_facet | O'Dwyer, Laurence Nolan, Lorraine Fisher, Caitriona |
author_sort | O'Dwyer, Laurence |
collection | PubMed |
description | New technologies and our ever-increasing knowledge provide an exciting potential to develop innovative health products that can address challenges such as chronic diseases and ultimately improve outcomes for patients. Ireland has a strategic focus on supporting innovation and offers an ideal environment for health product innovation. This is due to the expertise and experience that is available within the life sciences sector and an established national infrastructure which supports the translation of research into health products in a collaborative manner. The Health Products Regulatory Authority (HPRA) is committed to supporting innovation for health products. Anyone developing an innovative health product can obtain regulatory guidance via the HPRA's Innovation Office. Scientific advice and a product classification service are also available. The HPRA is actively engaging with innovators through an outreach programme to discuss how regulation can support innovation and to raise awareness of available supports. In order to facilitate the appropriate regulation of innovative therapies, the HPRA is performing horizon scanning to identify innovations at an early stage of development, so that proactive action can be taken to put in place any additional regulatory tools or develop any expertise required to regulate such products and provide safe and timely access for patients. |
format | Online Article Text |
id | pubmed-6945904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-69459042020-01-27 Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products O'Dwyer, Laurence Nolan, Lorraine Fisher, Caitriona Biomed Hub Article New technologies and our ever-increasing knowledge provide an exciting potential to develop innovative health products that can address challenges such as chronic diseases and ultimately improve outcomes for patients. Ireland has a strategic focus on supporting innovation and offers an ideal environment for health product innovation. This is due to the expertise and experience that is available within the life sciences sector and an established national infrastructure which supports the translation of research into health products in a collaborative manner. The Health Products Regulatory Authority (HPRA) is committed to supporting innovation for health products. Anyone developing an innovative health product can obtain regulatory guidance via the HPRA's Innovation Office. Scientific advice and a product classification service are also available. The HPRA is actively engaging with innovators through an outreach programme to discuss how regulation can support innovation and to raise awareness of available supports. In order to facilitate the appropriate regulation of innovative therapies, the HPRA is performing horizon scanning to identify innovations at an early stage of development, so that proactive action can be taken to put in place any additional regulatory tools or develop any expertise required to regulate such products and provide safe and timely access for patients. S. Karger AG 2017-11-21 /pmc/articles/PMC6945904/ /pubmed/31988952 http://dx.doi.org/10.1159/000481427 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Article O'Dwyer, Laurence Nolan, Lorraine Fisher, Caitriona Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products |
title | Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products |
title_full | Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products |
title_fullStr | Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products |
title_full_unstemmed | Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products |
title_short | Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products |
title_sort | supporting innovation through regulation and science: ireland as an innovation hub for health products |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945904/ https://www.ncbi.nlm.nih.gov/pubmed/31988952 http://dx.doi.org/10.1159/000481427 |
work_keys_str_mv | AT odwyerlaurence supportinginnovationthroughregulationandscienceirelandasaninnovationhubforhealthproducts AT nolanlorraine supportinginnovationthroughregulationandscienceirelandasaninnovationhubforhealthproducts AT fishercaitriona supportinginnovationthroughregulationandscienceirelandasaninnovationhubforhealthproducts |